Ionica Sciences has developed an adaptable, sensitive, and easy-to-use platform for the detection of infectious and other diseases. The platform uses surface-enhanced Raman scattering, combined with DNA aptamers, to detect proteins and other antigens associated with human disease. IonLyme™ is the companies first high sensitivity test for Lyme disease in humans.
Ionica Sciences current focus is on the development of diagnostic tests for other tick borne diseases, mosquito borne viruses, and sexually transmitted diseases.
The company is a tenant in the Kevin M. McGovern Family Center for Venture Development in the Life Sciences.